English
Back
Download
Log in to access Online Inquiry
Back to the Top

avatar
CPS9113 Private ID: 101772360
No profile added yet
Follow
    This is the first updata in 2022.
    Good luck with the stock market in 2022!
    haha, let's see the biggest movers in last week.
    Top 10 movers for large-cap value stocks
    Top 10 movers for large-cap growth stocks
    Top 10 movers for large-cap core stocks
    Happy new year!
    Weekly Recap | Movers for large-cap stocks
    Weekly Recap | Movers for large-cap stocks
    Weekly Recap | Movers for large-cap stocks
    +1
    4
    11
    $Moderna (MRNA.US)$ I wonder if its drop is to do with Oxfam reporting them to the SEC, and whether they are mature enough to handle this. Spooky for Wall Street for sure
    $The Health Care Select Sector SPDR® Fund (XLV.US)$
    This is the major healthcare ETF
    A look at the top chart and you can see the nearly 5 months of consolidation and a breakout to the upside
    The second MACD (used here as a momentum trend indicator) shows the red/green trend bars, (notice how the trend lines are in line with the bars). Now look back to the start of the indicator and you can see how the trend lines up with the price rise (the current indicator is much much stronger). Indicators lag by design (if they could predict future movement that would be a crystal ball) but they show us this has been set up to explode higher.
    Now the DMA (Displaced Moving Average used to spot trend reversals) on the bottom. The middle of the 3 horizontal lines is the trend, notice the break out (or up)! The blue line is the Moving Average and gives no indication it only tells you what is. The yellow is a forward shifted indicator (magic crystal ball). Notice once again a breakout!
    Now why is it breaking out? The majors in healthcare have NEVER had more money (I will avoid the why's just know they do). Now inflation is here and cash loses value everyday you hold it, but you know what doesn't???  Drugs!... tell me are your healthcare costs going down!? So now these companies have hundreds of billions of dollars losing value the longer they hold it (not to mention the tax man cometh). At this very same time we have the most drugs EVER trying to get approval/trials but the costs are going up and their limited cash on hand is losing value, see where this is going??? Mergers acquisitions and product agreements on a level NEVER seen before!
    Why am I writing this on a cold Saturday? Well you could buy this ETF (and limit your risk by its shear volume of assets BUT also limiting your possible gains in the right individual stocks) and make a lot of gains!... Or you could see this as a big ol' buy signal 🚀🚀🚀 for individual stocks in the healthcare sector. Some of my picks are
    $Deciphera Pharmaceuticals (DCPH.US)$
    $ChemoCentryx (CCXI.US)$
    $Cortexyme (CRTX.US)$
    $180 Life Sciences (ATNF.US)$
    $CorMedix (CRMD.US)$
    $Aurinia Pharmaceuticals (AUPH.US)$
    $Citius Pharmaceuticals (CTXR.US)$
    $Coherus BioSciences (CHRS.US)$
    edit
    oh hahaha I forgot $Biofrontera (BFRI.US)$ I keep thinking of it as more of a meme and less as a pharma play😄
    Healthcare 🌋
    2
    $Biofrontera (BFRI.US)$ selling for a loss would be a mistake... There are still no shares to borrow and this will rebound well. remember the market takes from the impatient and rewards the patient. on the flip side this is not a bad spot to look for an entry point once this settles a bit and shows a reversal
    11
    $Novavax (NVAX.US)$ Just found this latest article from The New England Journal of Medicine.
    https://www.nejm.org/doi/full/10.1056/NEJMoa2116185#nav
    In Conclusion, NVX-CoV2373 was safe and effective for the prevention of COVID-19. Most breakthrough cases were caused by contemporary variant strains.
    In the process of the Fed's interest rate hike, if economic growth is synchronized with it, it will not have a significant negative impact on stocks. If the real interest rate is still in a negative range, it will still support stock valuations, so we are not particularly worried about the negative impact of the Fed's interest rate hike on US stocks, especially stocks with higher valuations.
    $SPDR S&P 500 ETF (SPY.US)$ $Tesla (TSLA.US)$ $NVIDIA (NVDA.US)$ $Advanced Micro Devices (AMD.US)$ $Rivian Automotive (RIVN.US)$
    Shares of several companies in the broader tech sector, including $Advanced Micro Devices (AMD.US)$ , are trading lower Thursday afternoon as investors weigh Wednesday's Fed announcements and assess the tapering outlook.
    The Federal Reserve announced that it will stop buying bonds about three months earlier than initially planned. The Fed now plans to trim its monthly Treasury and mortgage-backed security purchases by $30 billion a month starting next month. The new pace is expected to put an end to bond buying by March.
    The Fed also announced that it would leave interest rates unchanged at near-zero percent. The announcement paves the way for three interest rate hikes by the end of 2022, which could weigh on tech and growth stocks.
    Advanced Micro Devices designs microprocessors for the computer and consumer electronics industries. The majority of the company's sales are in the personal computer and data center markets via CPUs and GPUs.
    2021 is a year of volatility. It has witnessed the rise of meme stocks, starting with $GameStop (GME.US)$ and WallStreeBets early in January and up to the moon $AMC Entertainment (AMC.US)$ in June. After the 2020 pandemic, S&P 500 rallied 100% within 354 trading days*. In times of chip shortage, investors are also watching the tech stocks closely. Not to mention dramas like what caused by Elon Musk and Donald Trump on $Tesla (TSLA.US)$ and $Digital World Acquisition Corp (DWAC.US)$ . What a year!
    *Source: CNBC Maekets News
    Review Your 2021 to Win Free Stocks
    As 2021 comes to an end, moomoo invites you to write your own review of 2021 trading journey, reflecting on the year that was and looking ahead to 2022. Join the topic discussion "2021 in Review: My Investing Journey Forges Ahead" and get rewards now! 
    Event Duration: Now to December 31st, 11:59pm ET
    Rewards*:
    1. Top 40 posts will get FREE stock with a price range from $5 to $30.
    2. 9 Growing Stars of the Year* will get FREE stock with a price range from $20 to $50.
    3. All relevant posts with no less than 20 words will be rewarded with 88 points.
    *Participants before December 22nd stand a chance to become Growing Stars of the Year, which is a title given by moomoo community to reward your effort made in 2021. A badge will be given to Growing Stars on the profile page to acknowledge your progress and achievement. The Growing Star will be rewarded with one random moomoo merchandise and one free stock with a price range from $20 to $50. 
    *Note: One can only get one out of the three rewards mentioned above.
    The above rewards will be issued in 15 working days after the event ends.
    Selection criteria:
    (applied to both Top 40 posts and Growing Stars)
    1. Content quality: a comprehensive review of 2021.
    2. Good typesetting with order histories, stock's trend or other helpful charts.
    3. User interaction with the post.
    4. Relevant tickers added.
    How to join?
    Click here and join the discussion under the topic, and you stand a chance to win the free stocks! Easy peasy!
    Don't know what to write? Ask yourself the following three questions!
    ONE: How did your trades perform?
    As we approach the end of 2021, it's time to look back on whether you make money over 2021! Where did you put your money in? Did your stocks bring you good returns? What are your highlights this year in trading? 
    Reviewing your trading performance is a way to acknowledge successes and drawbacks to improve your trading skills. Let's check out what moomoo features you could adopt to assist the writing of your reviews here.
    TWO: What have you learned from trading? 
    Perhaps you made a profit, learned a new trading skill, developed good trading psychology, broke bad habits, and gained more confidence.
    Even if 2021 might not be the best year in trading, time must have rewarded you with something greater than money, and that is AWESOME! What lesson did you learn, and what progress did you make? Write down the trading knowledge you've learned over the year now!
    THREE: What cool thins have you done? 
    2020 might be the worst year for many people as COVID-19 took away so many innocent lives. Is 2021 getting better with you? What are your stories this year? Did you meet any good fellows during your trading journey? 
    We are all ears for your remarkable stories! Please remember, mooers will always be by your side no matter what happens.
    Final Words: 2022 Will Be Everything You Want It To Be
    Moving forward, it isn't just about learning from what didn't' work in 2021, but also about learning, acknowledging, and genuinely appreciating what did work in the past. You should allow yourself to be happy and truly soak it all in if you want to thrive.
    Happy (almost) 2022, and remember, this year—it's going to be what you want it to be.
    Join discussion and get rewards now! Click here: "2021 in Review: My Investing Journey Forges Ahead"
    *Write Your Original Ideas: Plagiarism or cheating is not acceptable in any activities on moomoo. Please "Report" the suspicious posts if you find any. Once confirmed, the user committed shall be disqualified from the activities.
    moomoo annual ceremony is happening right now! Check it out here:  2021 in Review: Grow Together to the Moon!
    Write 2021 Review to Win Free Stocks
    39
    14